Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Transmission of multidrug-resistant tuberculosis in the USA: a cross-sectional study.

Moonan PK, Teeter LD, Salcedo K, Ghosh S, Ahuja SD, Flood J, Graviss EA.

Lancet Infect Dis. 2013 Sep;13(9):777-84. doi: 10.1016/S1473-3099(13)70128-2.

2.

Transmission of multidrug-resistant tuberculosis in the UK: a cross-sectional molecular and epidemiological study of clustering and contact tracing.

Anderson LF, Tamne S, Brown T, Watson JP, Mullarkey C, Zenner D, Abubakar I.

Lancet Infect Dis. 2014 May;14(5):406-15. doi: 10.1016/S1473-3099(14)70022-2.

3.

Transmission of multidrug-resistant tuberculosis.

Schaaf HS, Van Rie A, Gie RP, Beyers N, Victor TC, Van Helden PD, Donald PR.

Pediatr Infect Dis J. 2000 Aug;19(8):695-9.

PMID:
10959735
4.

Nationwide survey of drug-resistant tuberculosis in the United States.

Bloch AB, Cauthen GM, Onorato IM, Dansbury KG, Kelly GD, Driver CR, Snider DE Jr.

JAMA. 1994 Mar 2;271(9):665-71.

PMID:
8080502
5.

Rapid impact of effective treatment on transmission of multidrug-resistant tuberculosis.

Dharmadhikari AS, Mphahlele M, Venter K, Stoltz A, Mathebula R, Masotla T, van der Walt M, Pagano M, Jensen P, Nardell E.

Int J Tuberc Lung Dis. 2014 Sep;18(9):1019-25. doi: 10.5588/ijtld.13.0834.

6.

Multidrug-resistant tuberculosis: treatment outcome in Denmark, 1992-2007.

Bang D, Lillebaek T, Thomsen VØ, Andersen AB.

Scand J Infect Dis. 2010 Apr;42(4):288-93. doi: 10.3109/00365540903456282.

PMID:
20082573
7.

[Tuberculosis Laboratory Surveillance Network (TuLSA) study group. The first step for national tuberculosis laboratory surveillance: Ankara, 2011].

Sezen F, Albayrak N, Özkara Ş, Karagöz A, Alp A, Duyar Ağca F, İnan Süer A, Müderris T, Ceyhan İ, Durmaz R, Ertek M; Tüberküloz Laboratuvar Sürveyans Ağı Tulsa Çalışma Grubu, Tulsa..

Mikrobiyol Bul. 2015 Apr;49(2):143-55. Turkish.

8.

Two simultaneous outbreaks of multidrug-resistant tuberculosis--Federated States of Micronesia, 2007-2009.

Centers for Disease Control and Prevention (CDC)..

MMWR Morb Mortal Wkly Rep. 2009 Mar 20;58(10):253-6.

9.

Epidemiology of pyrazinamide-resistant tuberculosis in the United States, 1999-2009.

Kurbatova EV, Cavanaugh JS, Dalton T, Click ES, Cegielski JP.

Clin Infect Dis. 2013 Oct;57(8):1081-93. doi: 10.1093/cid/cit452.

10.

Nosocomial transmission of Mycobacterium bovis resistant to 11 drugs in people with advanced HIV-1 infection.

Guerrero A, Cobo J, Fortún J, Navas E, Quereda C, Asensio A, Cañón J, Blazquez J, Gómez-Mampaso E.

Lancet. 1997 Dec 13;350(9093):1738-42.

PMID:
9413465
11.

Use of GenoType® MTBDRplus assay to assess drug resistance and mutation patterns of multidrug-resistant tuberculosis isolates in northern India.

Maurya AK, Singh AK, Kant S, Umrao J, Kumar M, Kushwaha RA, Nag VL, Dhole TN.

Indian J Med Microbiol. 2013 Jul-Sep;31(3):230-6. doi: 10.4103/0255-0857.115625.

12.

Direct Detection by the Xpert MTB/RIF Assay and Characterization of Multi and Poly Drug-Resistant Tuberculosis in Guinea-Bissau, West Africa.

Rabna P, Ramos J, Ponce G, Sanca L, Mané M, Armada A, Machado D, Vieira F, Gomes VF, Martins E, Colombatti R, Riccardi F, Perdigão J, Sotero J, Portugal I, Couto I, Atouguia J, Rodrigues A, Viveiros M.

PLoS One. 2015 May 27;10(5):e0127536. doi: 10.1371/journal.pone.0127536.

13.

A close-up on the epidemiology and transmission of multidrug-resistant tuberculosis in Poland.

Jagielski T, Brzostek A, van Belkum A, Dziadek J, Augustynowicz-Kopeć E, Zwolska Z.

Eur J Clin Microbiol Infect Dis. 2015 Jan;34(1):41-53. doi: 10.1007/s10096-014-2202-z.

PMID:
25037868
14.

Prevalence of multidrug resistance in Mycobacterium tuberculosis isolates from HIV seropositive and seronegative patients with pulmonary tuberculosis in north India.

Sethi S, Mewara A, Dhatwalia SK, Singh H, Yadav R, Singh K, Gupta D, Wanchu A, Sharma M.

BMC Infect Dis. 2013 Mar 15;13:137. doi: 10.1186/1471-2334-13-137.

16.

Multidrug resistant tuberculosis: prevalence and risk factors in districts of metema and west armachiho, Northwest Ethiopia.

Mekonnen F, Tessema B, Moges F, Gelaw A, Eshetie S, Kumera G.

BMC Infect Dis. 2015 Oct 26;15:461. doi: 10.1186/s12879-015-1202-7.

17.

Extensively drug-resistant tuberculosis in california, 1993-2006.

Banerjee R, Allen J, Westenhouse J, Oh P, Elms W, Desmond E, Nitta A, Royce S, Flood J.

Clin Infect Dis. 2008 Aug 15;47(4):450-7. doi: 10.1086/590009.

18.

Resistance patterns among multidrug-resistant tuberculosis patients in greater metropolitan Mumbai: trends over time.

Dalal A, Pawaskar A, Das M, Desai R, Prabhudesai P, Chhajed P, Rajan S, Reddy D, Babu S, Jayalakshmi TK, Saranchuk P, Rodrigues C, Isaakidis P.

PLoS One. 2015 Jan 21;10(1):e0116798. doi: 10.1371/journal.pone.0116798.

19.

Genotyping and clinical characteristics of multidrug and extensively drug-resistant tuberculosis in a tertiary care tuberculosis hospital in China.

Yuan X, Zhang T, Kawakami K, Zhu J, Zheng W, Li H, Deng G, Tu S, Liu W.

BMC Infect Dis. 2013 Jul 12;13:315. doi: 10.1186/1471-2334-13-315.

20.

Identifying Hotspots of Multidrug-Resistant Tuberculosis Transmission Using Spatial and Molecular Genetic Data.

Zelner JL, Murray MB, Becerra MC, Galea J, Lecca L, Calderon R, Yataco R, Contreras C, Zhang Z, Manjourides J, Grenfell BT, Cohen T.

J Infect Dis. 2016 Jan 15;213(2):287-94. doi: 10.1093/infdis/jiv387.

PMID:
26175455
Items per page

Supplemental Content

Support Center